Inovio Pharmaceuticals (INO)
Inovio (INO) appreciated roughly 16% on Thursday as concern about the novel coronavirus intensified. Recently, the Coalition for Epidemic Preparedness Innovations (CEPI)grantedInovio $9 million in funding to begin a clinical trial for a vaccine to prevent infection from the Wuhan coronavirus (2019-nCoV). ARK believes CEPI's grant highlights the strength of Inovio's platform in developing novel immunotherapies for both infectious disease and cancer.
from Catherine Wood's ARK investment newsletter
Inovio (INO) appreciated roughly 16% on Thursday as concern about the novel coronavirus intensified. Recently, the Coalition for Epidemic Preparedness Innovations (CEPI)grantedInovio $9 million in funding to begin a clinical trial for a vaccine to prevent infection from the Wuhan coronavirus (2019-nCoV). ARK believes CEPI's grant highlights the strength of Inovio's platform in developing novel immunotherapies for both infectious disease and cancer.
from Catherine Wood's ARK investment newsletter